FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 3211334 · Received July 8, 2013

Report

Report Number
2124215-2013-08456
Event Type
Malfunction
Date Received
July 8, 2013
Date of Event
May 15, 2013
Report Date
May 15, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

THE VENTRICULAR TACHYCARDIA (VT) RATE CUTOFF WILL BE REPROGRAMMED TO MITIGATE THE INAPPROPRIATE SHOCKS. RECORDS INDICATE THIS DEVICE REMAINS IN SERVICE. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT IMPLANTED WITH THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) RECEIVED NUMEROUS INAPPROPRIATE SHOCKS FOR SUPRAVENTRICULAR TACHYCARDIA (SVT) WHICH EXHAUSTED THERAPY. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
309518 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 49 YR 0158| 4136| E110